VaccineAnimalsMiceInbred BALB CAntibodiesViral
Herpes zoster mRNA vaccine elicits superior immune responses over licensed vaccines with a favorable safety profile in animal models.
Yan Chen, Qi Liu, Chunxia Wang, Shaoyi Chen, Shuang Li, Jun Liu, Liping Luo, Zhendong Zhang, Jiaru Cai, Minhe Huang, Ronglin Xie, Yucai Peng
Published: 202610.1016/j.vaccine.2025.128136
Abstract
Herpes zoster, a painful rash that is commonly known as shingles, occurs when the varicella-zoster virus is reactivated from its latent state in neurons. The condition is more frequent among older or immunocompromised individuals. Although the licens…
Preview only. Read the full abstract at the source